Chronic HCV infection affects an estimated 3% of the world’s population (>180 million people) and is a worldwide health problem causing end-stage liver diseases including hepatocellular carcinoma (HCC). The development of HCV-related HCC occurs by advanced fibrosis or cirrhosis. The … Read More
Respiratory viral infections such as SARS-CoV-2 and influenza are a leading cause of morbidity and mortality, accounting for approximately 2 million deaths per year and an even higher healthcare burden during pandemics. Individuals over the age of 65 in particular, … Read More
Cachexia, or the inflammatory loss of lean body mass, is a leading predictor of morbidity across chronic diseases. A disease of complex etiology, cachexia has proven difficult to model in animals. Little is known regarding the molecular mechanisms controlling cachexia … Read More
Kristin Anderson, PhD, a resident faculty member of the Carter Immunology Center, and an assistant professor in the Department of Microbiology, Immunology, and Cancer Biology, earned a NIH Research Career Development (K) Award in the fourth quarter of FY23. K … Read More
Apart from the acute illness caused by SARS-CoV-2, it is now clear that a significant percentage of patients develop long term conditions post COVID-19, including systemic and respiratory symptoms. Given the catastrophic spread of SARS CoV-2 infection globally, there are … Read More
Oom Pattarabanjird (MSTP trainee with the McNamara lab) received an award for top poster at the recent Atherosclerosis Gordon Conference in Barcelona for her poster entitled “Human Marginal Zone B cells Produce Atheroprotective IgM and Confer Protection from Vascular Disease.” … Read More
It is with great sadness we share news about the passing of a dear friend and colleague, Thomas J. Braciale, MD, PhD. Dr. Braciale passed away Friday, May 19, 2023 with his family at his side. Dr. Braciale was a … Read More
My work focuses on the role of immune cells in heart and vascular disease. It’s a new field with novel discovery, and we’re identifying new pathways related to heart disease every day that can be translated to help our patients.— … Read More
The new research from UVA’s Jie Sun, PhD, and colleagues suggests a way to protect patients with obesity or diabetes from the runaway inflammation and dangerous blood sugar spikes that COVID-19 can cause. Such patients are at high risk for … Read More
Title: Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis Amount: 2.2M (~440K/year). Dates: 3/1/23 – 2/27/28 Congratulations Dr. Rutkowski!
